Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort

Jeffrey J. Post, Yong Pan, Anthony J. Freeman, Charles E. Harvey, Peter A. White, Patricia Palladinetti, Paul S. Haber, George Marinos, Michael H. Levy, John M. Kaldor, Kate A. Dolan, Rosemary A. Ffrench, Andrew R. Lloyd, William D. Rawlinson

Research output: Contribution to journalArticleResearchpeer-review

121 Citations (Scopus)

Abstract

Understanding the earliest virological and immunological events in acute hepatitis C virus (HCV) infection may provide insight into the determinants of protective immunity. Four cases of HCV viremia with subsequent viral clearance, but without biochemical hepatitis or anti-HCV seroconversion, are reported from a prospective cohort study of prison inmates. Two of the subjects who developed sustained viremia were assessed for production of interferon (IFN)-γ, by use of the enzyme-linked immunospot (ELISPOT) method and by assessment of HCV cytotoxic T lymphocyte (CTL) activity, CD4 lymphocyte proliferative responses, HCV load, and genotype. After 2-6 months of viremia, all 4 subjects cleared serum HCV RNA. Specific cellular responses were detected in both of the subjects who were assessed, and production of IFN-γ was demonstrated in one subject. All subjects had weak, but consistent, serological reactivity against HCV nonstructural proteins on immunoblot testing, despite repeatedly nonreactive HCV ELISA tests. These cases highlight the potential for cellular immune responses against HCV to facilitate viral clearance, responses that may model those required for effective HCV vaccination.

Original languageEnglish
Pages (from-to)1846-1855
Number of pages10
JournalJournal of Infectious Diseases
Volume189
Issue number10
DOIs
Publication statusPublished - 15 May 2004
Externally publishedYes

Cite this